RNS Number: 3350 T Frontier IP Group plc 13 November 2019 RNS. As previously announced, the Company's Annual General Meeting will be held at 11 am on 4 December 2019 at 93 George Street, Edinburgh, EH2 3 ES.. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 6763 S Frontier IP Group plc 07 November 2019 TR-1: S tandard form for notification of major holdings. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 5190 S Frontier IP Group plc 06 November 2019 THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA, AUSTRALIA, NEW ZEALAND OR ANY OTHER JURISDICTION WHERE TO DO SO...
RNS Number: 3949 S Frontier IP Group plc 06 November 2019 THIS ANNOUNCEMENT, INCLUDING THE APPENDIX, AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA, AUSTRALIA, NEW ZEALAND OR ANY OTHER...
Financial highlights· Fair value of our portfolio increased by 47% to £13,252,000. ·Total revenue increased by 81% to £4,268,000- reflecting an unrealised profit on the revaluation of investments of £3,850,000. ·Revenue from services increased by 40% to £418,000.
RNS Number: 6114 Q Frontier IP Group plc 22 October 2019 RNS REACH. Frontier IP appoints senior advisers to step up industry engagement. Frontier IP, a specialist in commercialising university intellectual property, today announces the appointment of John Price and Air Vice-Marshal Gary Waterfall CBE as specialist advisers to deepen and expand the Group and...
RNS Number: 8235 P Frontier IP Group plc 15 October 2019 15 October 2019. Portfolio news- new portfolio company Elute Intelligence Holdings. Elute is being formed from an existing UK business, CFL Software Limited, and will also include complementary intellectual property developed by Frontier IP.
RNS Number: 7126 L Frontier IP Group plc 10 September 2019 10 September 2019. Frontier IP, a specialist in commercialising university intellectual property, announces the appointment of Nplus1 Singer Advisory LLP as the Group's sole broker with immediate effect.. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in...
Frontier IP Group (FIPP) 68.50p £28.85m Frontier IP, a specialist in commercialising university intellectual property, noted the following announcement from portfolio company Exscientia, a world leader in artificial intelligence ("AI") drug discovery, that it has entered into a drug discovery collaboration with Rallybio. Rallybio is a US-based drug development company aiming to transform the lives of patients with rare diseases. Exscientia's other partnerships include collaborations with Celgene, GSK, Roche, Sanofi, GT Apeiron and Evotec. Frontier IP currently holds a 3.25% stake in the Company.
Frontier IP Group Plc (FIPP.L) Announced that portfolio company Exscientia ("Exscientia" or the "Company"), a world leader in artificial intelligence ("AI") drug discovery, has entered into a drug discovery collaboration with Rallybio. Rallybio is a US-based drug development company aiming to transform the lives of patients with rare diseases.
RNS Number: 6261 G Frontier IP Group plc 25 July 2019 RNS Reach. Portfolio news- Exscientia enters broad rare disease drug discovery collaboration with Rallybio. Exscientia, a world-leading Artificial Intelligence- driven drug discovery company, announced today that it has entered into a collaboration with Rallybio, a U.S.- based drug development company,...
RNS Number: 5571 F Frontier IP Group plc 15 July 2019 TR-1: S tandard form for notification of major holdings. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
Frontier IP (FIPP.L) 78.75p £33.1m Frontier IP, a specialist in commercialising university intellectual property, noted the following announcement from portfolio company Exscientia, a world leader in AI drug discovery, that it has entered into a drug-discovery partnership with GT Apeiron Therapeutics. GT Apeiron is a Shanghai-headquartered biotechnology drug-discovery platform launched with $27m backing from GT Healthcare Capital Partners, a life sciences-focused private equity partnership. GT Healthcare is also an investor in Exscientia. As part of the agreement, Exscientia is entitled to become a shareholder in GT Apeiron as well as receiving milestones and royalties based on the clinical and commercial success of each programme. GT Healthcare invested in Exscientia as part of a Series B financing round, which raised $26m to scale up the Company's pipeline and advance selected programmes towards clinical development. Further details were announced by Frontier IP on 7 Jan 2019. Exscientia's existing partnerships include collaborations with Celgene, GSK, Roche, Sanofi and Evotec. Frontier IP holds a 3.32% stake in the Company.
Frontier IP Group Plc (FIPP.L) Announced that its portfolio company Exscientia (Exscientia), a world leader in artificial intelligence (AI) drug discovery, has entered into a drug-discovery partnership with GT Apeiron Therapeutics (GT Apeiron). GT Apeiron is a Shanghai-headquartered biotechnology drug-discovery platform launched with $27 million backing from GT Healthcare Capital Partners (GT Healthcare), a life sciences-focused private equity partnership. GT Healthcare is also an investor in Exscientia. As part of the agreement, Exscientia is entitled to become a shareholder in GT Apeiron as well as receiving milestones and royalties based on the clinical and commercial success of each programme
RNS Number: 1681 C Frontier IP Group plc 14 June 2019 RNS Reach. GT Apeiron is a Shanghai- headquartered biotechnology drug-discovery platform launched with US $27 million backing from GT Healthcare Capital Partners, a life sciences-focused private equity partnership. GT Healthcare invested in Exscientia as part of a Series B financing round, which raised US...
RNS Number: 7460 A Frontier IP Group plc 31 May 2019 31 May 2019. Frontier IP, which specialises in commercialising university intellectual property, announces that the Company's issued share capital as at the date of this announcement comprises 42,431,372 ordinary shares, with one voting right per share. The Company does not hold any ordinary shares in...
RNS Number: 8104 A Frontier IP Group plc 31 May 2019 31 May 2019. Frontier IP, a specialist in commercialising university intellectual property, announces that David Cairns has notified the Group of his decision to step down from the Board. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
Frontier IP Group Plc (FIPP.L) Announced that portfolio company Fieldwork Robotics (the Company or Fieldwork) has completed initial field trials of its robot raspberry harvesting system. It holds 27.5 per cent of the company. Data from the trials will be used to refine and improve the prototype system before further field trials are held later this year. If the trials are successful, then manufacturing of a commercial system is expected to begin in 2020. The trials were held in West Sussex at a farm owned by Fieldwork's industry partner, leading UK soft-fruit grower Hall Hunter Partnership (Hall Hunter). Hall Hunter supplies Marks & Spencer, Tesco and Waitrose. The move follows University of Plymouth spin out Fieldwork being awarded a £547,250 Innovate UK grant earlier this year towards a £671,484 project to develop a multiarmed robot prototype. Other partners include the University of Plymouth and the National Physical Laboratory.
The trials were held in West Sussex at a farm owned by Fieldwork's industry partner, leading UK soft-fruit grower Hall Hunter Partnership. The move follows University of Plymouth spin out Fieldwork being awarded a £547,250 Innovate UK grant earlier this year towards a £671,484 project to develop a multi-armed robot prototype. Other partners include the...
RNS Number: 0324 Z Frontier IP Group plc 15 May 2019 15 May 2019. Exercise of options by a director. Frontier IP, a specialist in commercialising university intellectual property, announces that David Cairns has, on 14 May 2019, exercised options over a total of 325,000 ordinary shares of 10 pence each in the capital of the Company.
Bid
-
-
-
Ask
  • High
    -
  • OPEN
    -
  • VOL
    -
  • MKT CAP
    -m
  • LOW
    -
  • CLOSE
    -
  • AVG VOL
    -
  • SHARES IN ISSUE
    42.11M
Watchlist